Hypertension Diagnostics (Hypertension Diagnostics) EPS (Basic) : $0.00 (TTM As of Sep. 2019)

View and export this data going back to 1998. Start your Free Trial

What is Hypertension Diagnostics EPS (Basic)?

Hypertension Diagnostics's basic earnings per share (Basic EPS) for the three months ended in Sep. 2019 was $0.00. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Sep. 2019 was $0.00.

Hypertension Diagnostics's EPS (Diluted) for the three months ended in Sep. 2019 was $0.00. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Sep. 2019 was $0.00.

Hypertension Diagnostics's EPS without NRI for the three months ended in Sep. 2019 was $0.00. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Sep. 2019 was 0.00.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

Hypertension Diagnostics EPS (Basic) Historical Data

The historical data trend for Hypertension Diagnostics's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hypertension Diagnostics EPS (Basic) Chart

Hypertension Diagnostics Annual Data

Trend

Jun06

Jun07

Jun08

Jun09

Jun10

Jun11

Jun12

Dec16

Dec17

Dec18

EPS (Basic)

Get a 7-Day Free Trial

0.01

-0.03

Hypertension Diagnostics Quarterly Data
	Dec09	Mar10	Jun10	Sep10	Dec10	Mar11	Jun11	Sep11	Dec11	Mar12	Jun12	Sep12	Dec12	Mar13	Dec16	Dec17	Dec18	Mar19	Jun19	Sep19
EPS (Basic)	Get a 7-Day Free Trial															-	-	-	-	-

Hypertension Diagnostics EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Hypertension Diagnostics's Basic EPS for the fiscal year that ended in Dec. 2018 is calculated as

Basic EPS (A: Dec. 2018 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-0.125	-	0)	/	52.389
	=	-0.00

Hypertension Diagnostics's Basic EPS for the quarter that ended in Sep. 2019 is calculated as

Basic EPS (Q: Sep. 2019 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(0	-	0)	/	52.389
	=	0.00

EPS (Basic) for the trailing twelve months (TTM) ended in Sep. 2019 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00

Hypertension Diagnostics (OTCPK:HDII) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Hypertension Diagnostics EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Hypertension Diagnostics's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.